Indian Pharma Industry to Experience Negative Volume Growth in 3Q 2025: Report

New Delhi: The Indian pharmaceutical market (IPM) has returned to negative volume growth this Q3FY25 after two consecutive quarters of modest positive growth, according to Goldman Sachs report.However, strong pricing growth (+5.3 per cent YoY) and the launch of new products from

Read More

  • Related Posts

    Data Centres To Be A Major Pillar Of India’s Growth Story, Investments To Surpass $200 Billion: Ashwini Vaishnaw

    Union Minister for Electronics and Information Technology Ashwini Vaishnaw on Saturday highlighted India’s data centre boom, with $70 billion invested so far and expectations to reach $200 billion. This growth will create opportunities for startups, service providers, and AI inno Read More

    Piyush Goyal Hails Protection Of Farmers’ Interest Via India-US Interim Trade Pact – Key Details

    After the India-US issued a joint statement detailing the top points and key highlights of the India-US trade agreement, Union Minister of Commerce and Industry Piyush Goyal hailed it as a win for the South Asian nation’s farmers, fishing community, and MSME’s.As part of the fram Read More

    Leave a Reply

    Your email address will not be published. Required fields are marked *